Antigoni Lekka

12 Monis Petraki And Vasilissis Sofias Avenue
Athens, ESYE31 11528, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study.

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study.

Journal: Biomolecules

Published: September 06, 2021

Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab-treated patients: comment on the article by Simon et al.

Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab-treated patients: comment on the article by Simon et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 30, 2021

Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?

Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: August 20, 2019

Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer.

Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 05, 2018

Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.

Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.

Journal: Leukemia & lymphoma

Published: August 29, 2015

Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.

Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: October 28, 2014

Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.

Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.

Journal: Metabolism: clinical and experimental

Published: July 26, 2013

Hyperresistinemia is associated with postmenopausal breast cancer.

Hyperresistinemia is associated with postmenopausal breast cancer.

Journal: Menopause (New York, N.Y.)

Published: March 14, 2013

Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.

Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.

Journal: Clinical biochemistry

Published: November 10, 2012

Could serum visfatin be a potential biomarker for postmenopausal breast cancer?

Could serum visfatin be a potential biomarker for postmenopausal breast cancer?

Journal: Maturitas

Published: November 07, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026